Home / Medicine / Eryderm

Eryderm

Countries
Indonesia Netherlands Oman USA
Diseases
Dermatitis Infection Zits Acne Vulgaris Bronchitis Dysentery Pneumonia Enterocolitis Abscess Gonorrhea Infection,Soft Tissue Middle Ear Infection Fever Sepsis Syphilis Chronic Middle Ear Infection Endocarditis Pregnancy Gingivitis Dental Laryngitis Influenza Cold Tonsillitis Pharyngitis Endoscopy COPD,Acute Prevent Infections Enteritis Sinus Infection Otitis Externa Rheumatic fever Burns Pink eye Prostatitis Urethritis Cellulite Bronchopneumonia Pertussis Scarlet fever Cholecystitis Impetigo Blepharitis Cough Bronchiectasis Pelvic infections Paronychia Chlamydia Chlamydia trachomatis Brucellosis Lymphogranuloma venereum Sexually transmitted diseases Upper respiratory infection Intestinal amebiasis Mycoplasma pneumonia Trachoma Nongonococcal urethritis Legionnaires disease Diphtheria Whooping cough Bone infection Carbuncle Neonatal conjunctivitis Mastoiditis Peritonsillar abscess Pneumonia in children Serologic test for syphilis Ear infection Pharyngitis,streptococcal Furunculosis and carbunculosis
Ingredients
Erythromycin
Drug Actions
Antiacne Bacteriostatic Antibiotic combination
How does this drug class actually work?
Read the plain-language explainer in Pharmacology Academy (Antibiotics) →

Drugs with the same active ingredients

Acneout Atlamicin Eri Erimicin Erisine Erisol Eristin Erit bioquim Eritrobron Eritrobron forte Eritrofarm Eritromed Eritromicina atlas Eritromicina elea Eritromicina fabra Eritromicina klonal Eritrovis Eryacne Etisux Iloticina

Incompatibilities

Enteric coated tablets; Eye ointment; Lyophilizate for the preparation of a solution for intravenous administration; Ointment for external use; Substance-powderInjectable

None know

None stated.

Preclinical safety data

Enteric coated tablets; Eye ointment; Lyophilizate for the preparation of a solution for intravenous administration; Ointment for external use; Substance-powderInjectable

There are no preclinical data of relevance to the prescriber, which are additional to that already included in the other sections of the SPC

There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.

Special precautions for disposal and other handling

Enteric coated tablets; Eye ointment; Lyophilizate for the preparation of a solution for intravenous administration; Ointment for external use; Substance-powderInjectable

60 ml suspension: to reconstitute add 48 ml water and shake the bottle vigorously. The resulting suspension is yellow in colour.

100 ml suspension: to reconstitute add 80 ml water and shake the bottle vigorously. The resulting suspension is yellow in colour

140 ml suspension: to reconstitute add 112 ml water and shake the bottle vigorously. The resulting suspension is yellow in colour

Not applicable

Available in 4 countries